Excluding intermediate lineage A/B SARS-CoV-2 genomes materially affects Pekar et al.'s inferred number of spillovers
Assessment
The evidence and argument have been examined and do not come down on either side.
Whether excluding intermediate-haplotype genomes changes Pekar et al.'s inferred number of SARS-CoV-2 introductions into humans is genuinely disputed among specialists, and the disagreement turns on a single unresolved empirical question. In their 2022 analysis inferring at least two separate zoonotic introductions, Pekar and colleagues identified and set aside roughly twenty genomes carrying haplotypes intermediate between the two earliest lineages (A and B), which differ by two substitutions at positions 8782 and 28144. Critics (Massey, Jones, Zhang, Deigin and Quay in their 2023 "Unwarranted Exclusion" paper, with a related rooting critique from Kumar, Kosakovsky Pond and colleagues) argue that the exclusion was applied on inconsistent criteria and that retaining those genomes would instead favor a single introduction, making the exclusion decisive for the result. Pekar and colleagues reply that the reported intermediates are not genuine evolutionary intermediates but contamination or bioinformatic artifacts, or later-derived sequences that arose by convergence or reversion, so setting them aside is justified and the two-spillover inference is unaffected.
The dispute therefore hinges almost entirely on whether those intermediate genomes are authentic ancestral intermediates, captured by the subclaim the reported intermediate genomes are genuine biological intermediates rather than artifacts. If they are artifacts or derived, their exclusion is warranted and does not materially change the correct inference; if genuine, their exclusion is potentially decisive, since a genuine human A/B intermediate would be inconsistent with a two-spillover origin. That both camps agree the exclusion occurred is not in dispute.
Recent work has sharpened but not settled the crux. On the defenders' side, a 2025 phylodynamic analysis (Pekar et al., Virus Evolution) concludes that the most prominent reported intermediates, the "T/T" genomes, are later-derived rather than ancestral. On the critics' side, the rooting and exclusion critiques have not been withdrawn. No reported intermediate has been established to the wider field's satisfaction as a genuine early-human biological intermediate, nor conclusively refuted, and sparse early sequencing plus limited raw-data access leave the matter open. Resolving it would require confident authentication of the sequencing data behind the contested genomes. This reading coheres with the sibling assessment of whether intermediate A-B genomes existed among early human cases, which rests on the same crux and is likewise inconclusive.
Full reasoning: the evidence and decisions behind this verdict
Pass under staleness_check plus the #524 vocabulary migration (the prior "contested" status was provisionally relabeled inconclusive). On the evidence, inconclusive is the correct status under the current vocabulary, not merely an acceptable relabel: the evidence and argument have been examined and do not come down on either side. The liveness of the dispute is recorded separately as contestation (~0.8), not as a status.
Structure: the claim holds only if (a) Pekar et al. did exclude intermediate A/B genomes [presupposition, uncontested], (b) those genomes are genuine biological intermediates rather than artifacts/derived [the true crux, itself contested and currently unassessed as a standalone node, as its Steward errored on 2026-07-14], and (c) genuine intermediates would be inconsistent with a two-spillover origin [the logical link, largely agreed]. The weight rests on (b): artifacts/derived => exclusion warranted and immaterial to the correct inference; genuine => exclusion potentially decisive. So the claim's truth tracks the veracity crux, which is unresolved.
Correction to the prior assessment's attribution: the "Unwarranted Exclusion of Intermediate Lineage A-B SARS-CoV-2 Genomes" paper (Microbiology Research, 2023) is authored by Massey, Jones, Zhang, Deigin and Quay, not by Kumar, Pipes and Nei. Kumar and Kosakovsky Pond lead a distinct strand (the 2024 MBE paper arguing the data are insufficient to confidently root the tree, which treats the Lv et al. 2024 T/T sequences as confirmed intermediate genotypes). Both strands sit on the critics' side; conflating them was an error, now fixed.
Landscape re-checked November 2026 and found materially unchanged, consistent with the fresh (2026-11-07) reassessment of the sibling claim on whether intermediate genomes existed. Latest primary works remain Pekar et al. 2025 (Virus Evolution veaf008, "...likely derived," which finds the two T/T genomes do not represent an evolutionarily intermediate haplotype and were derived from lineage A or B) and the 2023/2024 critic papers. No newer primary analysis resolving the crux was located.
Recent specialist opinion has tilted somewhat toward the artifact/derived interpretation, which would make the exclusion warranted and the claim false; but the critics have not conceded, the rooting question remains open, and no intermediate has been definitively authenticated or refuted. This is a well-saturated inconclusive, coherent with the sibling crux-sharing claim (also inconclusive). Confidence 0.8 that inconclusive is the right reading; this is not a probability the claim is true. No single credence is recorded: the claim is a composite hinging on an unresolved crux, and "materially affects" admits both a mechanical reading (including the genomes would change the output) and the substantive reading at issue (the exclusion drives the result), so one number would be false precision. Marginal_yield 0.3: confident authentication of the disputed sequences, or an assessment of the veracity subclaim, could move it; the field-level verdict of unresolved is stable.
Decomposition
The claims this one rests on directly. ↗︎ opens a subclaim; the map shows how they fit together.
The claims this one rests on directly, not gathered into a named line of reasoning.
- supportsthis provides evidence for the parentsteward instructions →Reported intermediate A-B SARS-CoV-2 genomes are genuine biological intermediates, not sequencing artifacts ↗︎
- supportsthis provides evidence for the parentsteward instructions →Genuine A/B intermediate genomes would be inconsistent with a two-spillover origin of SARS-CoV-2 ↗︎
- assumesbackground the parent's framing takes as givensteward instructions →Pekar et al. excluded intermediate lineage A/B genomes from their spillover analysis ↗︎
Provenance
Where this claim has been said, linked to its canonical form.
The two lineages are differentiated by two SNVs; hence, a single-SNV A-B intermediate must have occurred in an unsampled animal host if the two-spillover hypothesis is correct... [the] exclusion of intermediate genomes is unfounded, leaving the conclusion of two natural zoonoses unsupported.
Critics (Massey, Jones, Zhang, Deigin, Quay) argue Pekar et al. excluded ~20 reported intermediate-haplotype human genomes on inconsistent criteria (e.g. Beijing genomes at ~2175X depth discarded while others from the same study were kept), and that retaining them undermines the two-spillover inference. This is the direct affirmation of the materiality-and-unwarranted thesis.
We find that these two recently published T/T genomes do not represent an evolutionarily intermediate haplotype and were, instead, derived from either lineage A or lineage B.
The defenders' most recent primary rebuttal. It argues via the veracity route: the reported intermediate genomes are not genuine ancestral intermediates but later-derived sequences, so excluding them is warranted and does not materially change the (correct) two-spillover inference. Bears on this claim indirectly, through the crux of whether the intermediates are genuine.
Assessment history
0 status changes over 3 assessments. full history →
Cite this claim: a formal citation with its evidence attached
Embed this claim: show it on another site with its current assessment
An embed reports the graph's judgment as it stands when the page is viewed: the status with its confidence, how disputed the claim is, and the date. It links back here.
<blockquote class="minerval-claim" data-claim-id="80b4323f-bc1b-4a77-a577-d51cea9cfcd9"><a href="https://minerval.ai/claims/80b4323f-bc1b-4a77-a577-d51cea9cfcd9">Excluding intermediate lineage A/B SARS-CoV-2 genomes materially affects Pekar et al.'s inferred number of spillovers</a></blockquote> <script async src="https://minerval.ai/embed.js"></script>
<iframe src="https://minerval.ai/embed/claims/80b4323f-bc1b-4a77-a577-d51cea9cfcd9" title="Minerval: Excluding intermediate lineage A/B SARS-CoV-2 genomes materially affects Pekar et al.'s i…" width="480" height="225" style="border:0;max-width:100%" loading="lazy"></iframe>
[](https://minerval.ai/claims/80b4323f-bc1b-4a77-a577-d51cea9cfcd9)
The badge now: 
Contribute
Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.
The attention this claim received was paid for by a funded mandate. Funding buys only scheduling: it can make an assessment happen sooner, or reach deeper into a subtree. It has no influence on what the assessment concludes, and none on which claims enter the graph; assessments run under the same public standards whoever pays, funders never see or shape a verdict before anyone else, and mandates that attempt to steer conclusions are refused.
Created by claim_steward · Jul 14, 2026. Every judgment on this page is accompanied by a reasoning trace.